MCF Advisors LLC

SEC CIK: 0001602905
Latest filing: Aug 12, 2026

SEC filings (opens in a new tab)

IBRX holding history

ImmunityBio, Inc. in every 13F filed by MCF Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

IBRX overview All 13F holders of IBRX Full Q2 2026 holdings

Shares (Q2 2026): 2,646
Value: $23.2K
% of portfolio: <0.1%
Quarters held: 4; Since Q3 2025

Holdings of IBRX by MCF Advisors LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	2,646	$23.2K	<0.1%	00.0%	Unchanged	Holders
Q1 2026	2,646	$20.3K	<0.1%	+500+23.3%	Added	Holders
Q4 2025	2,146	$4.25K	<0.1%	00.0%	Unchanged	Holders
Q3 2025	2,146	$5.28K	<0.1%	+2,146	New	Holders